CRIS
Price
$1.98
Change
+$0.06 (+3.12%)
Updated
May 23, 01:48 PM (EDT)
Capitalization
20.82M
ROIV
Price
$10.87
Change
-$0.08 (-0.73%)
Updated
May 23, 02:15 PM (EDT)
Capitalization
7.81B
6 days until earnings call
Interact to see
Advertisement

CRIS vs ROIV

Header iconCRIS vs ROIV Comparison
Open Charts CRIS vs ROIVBanner chart's image
Curis
Price$1.98
Change+$0.06 (+3.12%)
Volume$520
Capitalization20.82M
Roivant Sciences
Price$10.87
Change-$0.08 (-0.73%)
Volume$100
Capitalization7.81B
CRIS vs ROIV Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. ROIV commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and ROIV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CRIS: $1.92 vs. ROIV: $10.94)
Brand notoriety: CRIS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 0% vs. ROIV: 42%
Market capitalization -- CRIS: $20.82M vs. ROIV: $7.81B
CRIS [@Biotechnology] is valued at $20.82M. ROIV’s [@Biotechnology] market capitalization is $7.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • CRIS’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than CRIS.

Price Growth

CRIS (@Biotechnology) experienced а -4.00% price change this week, while ROIV (@Biotechnology) price change was +1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.70%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -2.88%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.81B) has a higher market cap than CRIS($20.8M). ROIV YTD gains are higher at: -7.523 vs. CRIS (-37.255). ROIV has higher annual earnings (EBITDA): 4.1B vs. CRIS (-44.56M). ROIV has more cash in the bank: 5.15B vs. CRIS (20.9M). CRIS has less debt than ROIV: CRIS (3.26M) vs ROIV (100M). ROIV has higher revenues than CRIS: ROIV (123M) vs CRIS (10.3M).
CRISROIVCRIS / ROIV
Capitalization20.8M7.81B0%
EBITDA-44.56M4.1B-1%
Gain YTD-37.255-7.523495%
P/E RatioN/A1.97-
Revenue10.3M123M8%
Total Cash20.9M5.15B0%
Total Debt3.26M100M3%
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRISROIV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 10 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JIRE68.560.03
+0.04%
JPMorgan International Rsrch Enh Eq ETF
AGD10.23N/A
N/A
abrdn Global Dynamic Dividend Fund
GDOC30.65-0.08
-0.26%
Goldman Sachs Future Health Care Eq ETF
SDIV21.17-0.07
-0.33%
Global X SuperDividend™ ETF
DMA8.88-0.08
-0.89%
Destra Multi-Alternative Fund

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with RCKT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
N/A
RCKT - CRIS
38%
Loosely correlated
N/A
ABEO - CRIS
37%
Loosely correlated
N/A
ROIV - CRIS
35%
Loosely correlated
+0.27%
VTGN - CRIS
34%
Loosely correlated
N/A
ORMP - CRIS
34%
Loosely correlated
N/A
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.27%
IMVT - ROIV
60%
Loosely correlated
N/A
CRNX - ROIV
53%
Loosely correlated
+0.53%
ACLX - ROIV
52%
Loosely correlated
-0.50%
KYMR - ROIV
51%
Loosely correlated
N/A
KRYS - ROIV
50%
Loosely correlated
N/A
More